C4 Therapeutics Q1 2026 Earnings EPS Surprises to the Upside as Biotech Focuses on Pipeline Execution RRC Q1 2026 Earnings EPS Surges Past Estimates by 19 Stock Slips as Market Weighs Sector Headwinds Core Scientific Q1 2026 Earnings Massive EPS Miss Amid Cryptocurrency Mining Headwinds Stock Edges Higher Cardiol Therapeutics CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates as PreRevenue Biotech Advances Pipeline IDCC Q1 2026 Earnings EPS Beats Estimates by 2269 Shares Dip Despite Strong Profit Performance